“…In particular, during chronic in ammation that occurs with liver cirrhosis, hematopoietic stem cell-associated disorders, chronic human immunode ciency virus (HIV) infection, myelodysplastic syndromes, ulcerative colitis and LRA, immune cells produce strong oxidizing genotoxic substances that are able to induce the cellular senescence [18][19][20][21]. In the in ammation milieu, pro-in ammatory cytokines are produced from stimulated lymphocytes by antigens or pathogens and activate immune cells, inhibit proliferation of transformed cells and intensify anti-viral/-tumor effects on cells; moreover, they also induce cellular senescence in diverse kinds of cells including melanocytes, endothelial cells and MSCs [10,[21][22][23][24][25]. Because cellular senescence is de ned as the irreversible changes that inhibit cellular division, growth, and function, senescent MSCs from an experimentally-induced model as well as RA and systemic lupus erythematosus (SLE) patients exhibit degradation of distinct cellular features, including differentiation potential, immunomodulation properties, misregulation of proin ammatory cytokine production and reduction in migratory ability [2,5,10,11,19,21,[23][24][25][26][27][28].…”